VIM
ALNY icon

VELA Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

VELA Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,818
Closed -$348K – 162
2023
Q4 		$348K Sell
1,818
-1,599
-47% -$272K 0.14% 141
2023
Q3 		$605K Hold
3,417
– – 0.27% 100
2023
Q2 		$649K Hold
3,417
– – 0.3% 96
2023
Q1 		$684K Buy
3,417
+92
+3% +$19.3K 0.31% 94
2022
Q4 		$790K Hold
3,325
– – 0.39% 81
2022
Q3 		$666K Buy
3,325
+350
+12% +$66.8K 0.38% 79
2022
Q2 		$434K Hold
2,975
– – 0.25% 104
2022
Q1 		$486K Buy
2,975
+544
+22% +$82.9K 0.31% 93
2021
Q4 		$412K Buy
+2,431
New +$452K 0.28% 103

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return